NCT05620251View on ClinicalTrials.gov

Response to BNT162b2 Vaccine in Adolescents With Type 1 Diabetes

CompletedOBSERVATIONAL
Enrollment

121

Participants

Timeline

Start Date

September 3, 2021

Primary Completion Date

February 28, 2022

Study Completion Date

June 12, 2022

Conditions
type1diabetes
Interventions
DIAGNOSTIC_TEST

Blood test

Assessment of humoral immune response

Trial Locations (1)

34722

Istanbul Medeniyet University, Professor Doctor Suleyman Yalcin city Hospital, Istanbul

All Listed Sponsors
lead

Istanbul Medeniyet University

OTHER

NCT05620251 - Response to BNT162b2 Vaccine in Adolescents With Type 1 Diabetes | Biotech Hunter | Biotech Hunter